Hematologic Malignancies
Original Research
RVD With Weekly Bortezomib Has a Favorable Toxicity and Effectiveness Profile in a Large Cohort of US Veterans With Multiple Myeloma
Case Reports
Chronic Myeloid Leukemia Presenting as Priapism: A Rare and Acute Initial Presentation in a Young Male
Case Reports
The First Female Patient in the Veteran Affairs System to Receive Chimeric Antigen Receptors (CAR) T-cell Therapy for Refractory Multiple Myeloma and the Role of CAR T-cell Therapy in Penta-refractory Disease
News
Is Location a Risk Factor for Early-Onset Cancer?
Early-onset cancer is on the rise. Researchers have studied a variety of factors driving the trend, such as type of cancer. However, geographic...
Supplements
Cancer Data Trends 2024
Article
Cancer Data Trends 2024: B-Cell Lymphoma
News
How Does Military Service Impact Cancer Risk? It’s Complicated
While it’s extremely difficult to link cancer rates to military service, researchers are starting to get some initial...
Conference Coverage
When to treat DLBCL with radiotherapy?
Choices depend on factors like evidence of disease, radiologists say.
Case Reports
Metastatic Urothelial Carcinoma Presenting as Mediastinal Lymphadenopathy Without Appreciable Bladder Mass in a Patient With Chronic Lymphocytic Leukemia
News
FDA approves motixafortide for stem cell mobilization in myeloma
Motixafortide has been approved by the FDA to help mobilize hematopoietic stem cells in autologous transplants for patients with multiple myeloma...